| 4.94 0.24 (5.11%) | 06-15 10:35 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 6.1 | 1-year : | 7.13 |
| Resists | First : | 5.23 | Second : | 6.1 |
| Pivot price | 4.7  |
|||
| Supports | First : | 4.51 | Second : | 4.07 |
| MAs | MA(5) : | 4.84  |
MA(20) : | 4.58 |
| MA(100) : | 3.89 |
MA(250) : | 5.61 |
|
| MACD | MACD : | 0.1 |
Signal : | 0.1 |
| %K %D | K(14,3) : | 62.3 |
D(3) : | 67 |
| RSI | RSI(14): 55 |
|||
| 52-week | High : | 15.84 | Low : | 2.55 |
Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.[ LFMD ] has closed below upper band by 35.4%. Bollinger Bands are 23.6% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 4.91 - 4.94 | 4.94 - 4.96 |
| Low: | 4.54 - 4.58 | 4.58 - 4.6 |
| Close: | 4.65 - 4.71 | 4.71 - 4.74 |
LifeMD, Inc. operates as a leading digital health company, specializing in direct-to-consumer telemedicine across the United States. The firm links individuals with licensed medical professionals to address a diverse spectrum of health concerns, including concierge services, men's sexual health, dermatological conditions, and more. Under its umbrella, LifeMD manages several specialized virtual care platforms: ShapiroMD is a telehealth brand focused on hair restoration, delivering virtual consultations, prescription medications, patented over-the-counter formulations, an FDA-cleared medical device, and custom-compounded topical treatments for both male and female hair loss. RexMD serves as a men's telehealth brand, providing virtual medical treatment from licensed providers for a wide array of male-specific health needs. LifeMD Primary Care offers a personalized, subscription-based virtual primary care solution, addressing routine, urgent, and chronic health management requirements. This mobile-centric platform integrates remote consultations, medication management, diagnostic services, and imaging referrals. Cleared is a telehealth service dedicated to offering personalized therapies for allergic, asthmatic, and immunological conditions. Nava MD stands as a skincare and tele-dermatology brand catering specifically to women, facilitating virtual access to dermatologists and other specialists for medical treatment. Additionally, the company provides PDFSimpli, a cloud-based software-as-a-service (SaaS) platform that empowers users to create, edit, convert, sign, and share PDF documents online. LifeMD distributes its offerings directly to individuals, via its own e-commerce channels, and through collaborations with external partners. Originally established in 1994 as Conversion Labs, Inc., the company rebranded to LifeMD, Inc. in February 2021 and is headquartered in New York City.
Tue, 09 Jun 2026
LifeMD: A Growing Healthcare Tech Stock, As Q1 Results Confirm Patient Demand - Seeking Alpha
Wed, 03 Jun 2026
LifeMD (LFMD) CTO receives 75,000-share time-vested stock grant - Stock Titan
Wed, 03 Jun 2026
LifeMD (LFMD) CTO Sripad Umesh submits initial Form 3 filing - Stock Titan
Thu, 28 May 2026
LifeMD Inc. (LFMD) Holds Steady Near Support as Volume Remains Subdued - Reversal Setup Alerts - lwvtexas.org
Wed, 06 May 2026
LifeMD adds 42,000 subscribers; women’s sign-ups jump 657% - Stock Titan
Wed, 06 May 2026
LifeMD, Inc. (LFMD) Reports Q1 Loss, Tops Revenue Estimates - Yahoo Finance
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Pharmaceuticals
|
|
| Shares Out | 48 (M) |
| Shares Float | 40 (M) |
| Held by Insiders | 14.4 (%) |
| Held by Institutions | 37.1 (%) |
| Shares Short | 5,590 (K) |
| Shares Short P.Month | 6,360 (K) |
| EPS | -0.44 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0.31 |
| Profit Margin | 2.9 % |
| Operating Margin | -17.8 % |
| Return on Assets (ttm) | -13.5 % |
| Return on Equity (ttm) | -238.5 % |
| Qtrly Rev. Growth | -1.4 % |
| Gross Profit (p.s.) | 3.47 |
| Sales Per Share | 3.99 |
| EBITDA (p.s.) | -0.3 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 8 (M) |
| Levered Free Cash Flow | -4 (M) |
| PE Ratio | -10.99 |
| PEG Ratio | 0 |
| Price to Book value | 15.1 |
| Price to Sales | 1.2 |
| Price to Cash Flow | 28.86 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|